Efficacy and safety of sargramostimt in moderate to severe Crohn's disease: Results of NOVEL 4, a phase III multicenter study

被引：0
|
作者：
Feagan, Brian G.
Anderson, Frank
Radford-smith, Gnaharn L.
Solovyov, Oleg
Zurdel-dillinger, Sabine
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A103 / A103
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn's disease: Results from the CELEST study
    Panes, J.
    Sandborn, W. J.
    Loftus, E. V., Jr.
    Van Assche, G.
    Ghosh, S.
    Zhou, Q.
    Goteti, S.
    Enejosa, J. V.
    Pangan, A. L.
    Lacerda, P.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S238 - S239
  • [2] EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE TREATMENT FOR MODERATE TO SEVERE CROHN'S DISEASE: RESULTS FROM THE CELEST STUDY
    Panes, Julian
    Sandborn, William J.
    Loftus, Edward V.
    Van Assche, Gert A.
    Ghosh, Subrata
    Zhou, Qian
    Goteti, Venkata Sasikiran
    Enejosa, Jeffrey V.
    Pangan, Aileen L.
    Lacerda, Ana P.
    GASTROENTEROLOGY, 2018, 154 (06) : S178 - S179
  • [3] Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Binion, David
    McHugh, Kevin
    Alam, Shamsul
    Chen, Naijun
    Guerette, Benoit
    Mulani, Parvez
    Chao, Jingdong
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (08): : 419 - 425
  • [4] Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
    Hyams, Jeffrey S.
    Griffiths, Anne
    Markowitz, James
    Baldassano, Robert N.
    Faubion, William A., Jr.
    Colletti, Richard B.
    Dubinsky, Marla
    Kierkus, Jaroslaw
    Rosh, Joel
    Wang, Yaqin
    Huang, Bidan
    Bittle, Barry
    Marshall, Michael
    Lazar, Andreas
    GASTROENTEROLOGY, 2012, 143 (02) : 365 - +
  • [5] THE VISIBLE 2 PHASE 3 STUDY OF EFFICACY AND SAFETY OF VEDOLIZUMAB SC FOR MODERATE-TO-SEVERE CROHN'S DISEASE
    Vermeire, Severine
    D'Haens, Geert R.
    Baert, Filip J.
    Danese, Silvio
    Kobayashi, Taku
    Loftus, Edward V.
    Bhatia, Siddharth
    Kisfalvi, Krisztina
    Rosario, Maria
    Zhang, Wenwen
    Sandborn, William J.
    GASTROENTEROLOGY, 2020, 158 (06) : S194 - S194
  • [6] Safety and Efficacy of Naltrexone Therapy in Children With Moderate to Severe Crohn's Disease: Pilot Study
    Smith, Jill P.
    Field, Douglas
    Bingaman, Sandra I.
    Evans, Robert
    Mauger, David T.
    GASTROENTEROLOGY, 2012, 142 (05) : S789 - S789
  • [7] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE IN BRAZIL
    Prra, Rogerio S.
    Chebli, Julio
    Chebli, Liliana
    Bertges, Erika R.
    Ambrogini Junior, Orlando
    Schiavetti, Bianca
    Alves, Antonio, Jr.
    Flores, Cristina
    Lubini, Marcio
    Gasparetti, Newton, Jr.
    Bafutto, Mauro
    Azevedo, Matheus
    Damiao, Aderson O.
    Queiroz, Natalia S.
    Steinwurz, Flavio
    Carvalho, Nayara S.
    Boratto, Sandra D.
    Vilela, Eduardo G.
    Feres, Omar
    Rocha, Jose Joaquim R.
    GASTROENTEROLOGY, 2021, 160 (06) : S414 - S415
  • [8] Primary efficacy and safety of mirikizumab in moderate to severe Crohn's Disease: results of the treat-through VIVID 1 study
    Ferrante, M.
    Danese, S.
    Chen, M.
    D'Haens, G.
    Ghosh, S.
    Hisamatsu, T.
    Jairath, V.
    Kierkus, J.
    Peyrin-Biroulet, L.
    Siegmund, B.
    Bragg, S. M.
    Crandall, W.
    Gibble, T. Hunter
    Lin, Z.
    Lopes, M. Ugolini
    Morris, N.
    Carlier, H.
    Sands, B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I7 - I9
  • [9] PRIMARY EFFICACY AND SAFETY OF MIRIKIZUMAB IN MODERATE TO SEVERE CROHN'S DISEASE: RESULTS OF THE TREAT-THROUGH VIVID 1 STUDY
    Sands, Bruce E.
    Danese, Silvio
    Chen, Minhu
    D'Haens, Geert
    Ghosh, Subrata
    Hisamatsu, Tadakazu
    Jairath, Vipul
    Kierkus, Jaroslaw
    Peyrin-Biroulet, Laurent
    Siegmund, Britta
    Bragg, Sonja M.
    Crandall, Wallace
    Gibble, Theresa H.
    Lin, Zhantao
    Lopes, Michelle
    Morris, Nathan
    Carlier, Hilde
    Ferrante, Marc
    GASTROENTEROLOGY, 2024, 166 (05) : S820 - S820
  • [10] A randomized, multicenter, open-label study to evaluate the safety and efficacy of infliximab in pediatric patients with moderate-to-severe Crohn's disease
    不详
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (04): : 539 - 539
12345